Edition:
United States

Brainstorm Cell Therapuetics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.78USD
15 Dec 2017
Change (% chg)

$-0.07 (-1.82%)
Prev Close
$3.85
Open
$3.85
Day's High
$3.85
Day's Low
$3.78
Volume
18,400
Avg. Vol
12,976
52-wk High
$5.15
52-wk Low
$2.40

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
FY 2016 Dec '16 0.00 -0.033
Sep '16 0.00 -0.086
Jun '16 0.00 -0.052
Mar '16 0.00 -0.096
FY 2015 Dec '15 0.00 -0.075
Sep '15 0.00 -0.141
Jun '15 0.00 -0.123
Mar '15 0.00 -0.123
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.00 0.00 0.00 --
Year Ending Dec-17 1 0.00 0.00 0.00 0.00
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-17 1 -0.27 -0.27 -0.27 -0.16
Quarter Ending Mar-18 1 -0.32 -0.32 -0.32 --
Year Ending Dec-17 1 -0.58 -0.58 -0.58 -0.61
Year Ending Dec-18 1 -1.18 -1.18 -1.18 -0.64
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 196.13 36.03
P/E High - Last 5 Yrs. -- 279.92 45.26
P/E Low - Last 5 Yrs. -- 93.48 24.26
Beta 1.51 0.82 0.91
Price to Sales (TTM) -- 117.54 5.90
Price to Book (MRQ) 13.71 23.08 5.74
Price to Tangible Book (MRQ) 13.71 26.92 7.33
Price to Cash Flow (TTM) -- 106.51 24.72
% Owned Institutions 8.71 5.59 1.38

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.48
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.02 5.23
Payout Ratio(TTM) -- 98.85 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -4.33 6.77
Sales (TTM) vs TTM 1 Yr. Ago -- 30.49 5.56
Sales - 5 Yr. Growth Rate -- 33.28 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -48.99 -148.85 7.88
EPS (TTM) vs TTM 1 Yr. Ago -1.45 -- --
EPS - 5 Yr. Growth Rate -- 44.44 10.92
Capital Spending - 5 Yr. Growth Rate 16.50 41.25 15.15

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.55
Current Ratio (MRQ) 1.78 5.63 3.57
LT Debt to Equity (MRQ) 0.00 16.33 13.26
Total Debt to Equity (MRQ) 0.00 18.85 19.22
Interest Coverage (TTM) -- -144.78 43.79

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.82 54.87
Gross Margin - 5 Yr. Avg. -- 55.59 52.44
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.54 15.70
Operating Margin (TTM) -- -635.70 6.77
Operating Margin - 5 Yr. Avg. -- -232.57 11.08
Pre-Tax Margin (TTM) -- -605.50 7.60
Pre-Tax Margin - 5 Yr. Avg. -- -232.71 11.49
Net Profit Margin (TTM) -- -603.22 3.83
Net Profit Margin - 5 Yr. Avg. -- -236.06 7.78
Effective Tax Rate (TTM) -- 15.54 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.17 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,216,302 857,902,259
Net Income/Employee (TTM) -- -2,116,531 100,310,105
Receivable Turnover (TTM) -- 26.19 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.00 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.76 -9.39 11.35
Return on Assets - 5 Yr. Avg. -71.19 0.13 12.32
Return on Investment (TTM) -74.44 -11.69 14.48
Return on Investment - 5 Yr. Avg. -91.15 3.37 16.13
Return on Equity (TTM) -74.44 -36.44 16.06
Return on Equity - 5 Yr. Avg. -93.46 5.73 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapuetics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.71%
# of Holders: 38
Total Shares Held: 1,640,687
3 Mo. Net Change: -754,233
# New Positions: 13
# Closed Positions: 7
# Increased Positions: 20
# Reduced Positions: 8
# Net Buyers: 12
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.